Valuation (33%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 36.12 | 30.45 |
PEG Ratio (TTM) | -26.73 | 85.57 |
P/S Ratio (TTM) | 5.38 | 6.36 |
P/B Ratio (TTM) | 2.01 | 6.17 |
P/FCF Ratio (TTM) | -17.21 | 3.28 |
Price to 5YR AVG Earnings Ratio | 50.78 | 171.30 |
Price to 5YR AVG FCF Ratio | -28.01 | -33.78 |
Profitability (35%) |
Company | Industry |
---|---|---|
ROA (TTM) | 2.40% | 1.22% |
ROE (TTM) | 5.67% | 8.96% |
Net Profit Margin (TTM) | 14.89% | -11.03% |
ROIC 5YR AVG | 2.05% | 3.91% |
Growth (52%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 3.45% | -15.85% | 7.30% |
Revenue | 2.67% | -2.58% | 3.19% |
Net Income | 3.24% | -13.47% | 10.91% |
Cash Flow | 28.29% | 23.97% | 18.12% |
Health (33%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.97 | 1.15 |
Quick Ratio (TTM) | 0.89 | 0.92 |
D/E Ratio (TTM) | 0.99 | 1.37 |
Interest Coverage (TTM) | 1.53 | 7.86 |
Piotroski F-Score | 6 | 5 |
Altman Z-Score | 1.46 | 1.88 |
LTL to 5YR AVG FCF | -10.51 | -29.34 |
Shares Outstanding Growth 5YR AVG | 3.31% | 2.61% |